Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
The administration of sodium valproate to 30 patients in daily doses of 1,200 to 3,000 mg was associated with a significant reduction of the platelet count. Thrombocytopenia without any concomitant bleeding abnormalities occurred in 10 of the patients. Platelet counts returned to baseline levels after withdrawal of the drug.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on